Bevacizumab

Bevacizumab is a medication that inhibits a protein called vascular endothelial growth factor (VEGF), which promotes the growth of new blood vessels. By blocking VEGF, bevacizumab reduces the blood supply to tumors or abnormal blood vessels, helping to slow or stop their growth. It is commonly used to treat certain cancers, like colorectal and lung cancer, and some eye conditions like age-related macular degeneration. While effective, it can cause side effects such as bleeding, high blood pressure, or delayed wound healing, so it is administered and monitored carefully by healthcare providers.